Aier Eye Hospital Group Co (300015) Q3 2025 earnings summary

Executive summary

• Revenue for Q3 2025 reached ¥5.98 billion, up 3.83% year-over-year; year-to-date revenue was ¥17.48 billion, up 7.25% year-over-year.

• Net profit attributable to shareholders for Q3 was ¥1.06 billion, down 24.12% year-over-year; year-to-date net profit was ¥3.11 billion, down 9.76% year-over-year.

• Cash flow from operating activities for Q3 was ¥5.08 billion, up 18.14% year-over-year.

Financial highlights

• Basic EPS for Q3 was ¥0.1151, down 24.33% year-over-year; year-to-date EPS was ¥0.3370, down 10.04% year-over-year.

• Total assets at quarter-end were ¥35.84 billion, up 7.76% from the previous year-end.

• Shareholders’ equity at quarter-end was ¥22.43 billion, up 8.3% from the previous year-end.

• Non-recurring losses for Q3 totaled ¥15.75 million; year-to-date non-recurring losses were ¥4.7 million.

Outlook and guidance

• Management highlighted increased investments and acquisitions, with a focus on expanding financial assets and property holdings.